← Open Payments lookup

CASSANDRA THOMPSON: Open Payments

NPI 1144396441 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,277 in 46 payments from 10 companies in 2025. Trend: 2023 $2,598 · 2024 $3,041 · 2025 $1,277

Food & beverage: $1,277
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$281
Otsuka America Pharmaceutical, Inc.8$249
Neurocrine BioSciences, Inc.3$191
Lundbeck LLC9$186
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$181
Vanda Pharmaceuticals Inc.2$62
Alkermes, Inc.3$56
Janssen Pharmaceuticals, Inc1$33
ABBVIE INC.1$20
Teva Pharmaceuticals USA, Inc.1$18

Products named: COBENFY, ABILIFY ASIMTUFII, INGREZZA, CAPLYTA, ABILIFY MAINTENA, REXULTI, ARISTADA, FANAPT.

Industry payments across DC — which companies pay providers there.